方达控股(01521.HK)全年经调整纯利增长28.7%至2139.7万美元
格隆汇3月30日丨方达控股(01521.HK)发布全年业绩,截至2019年12月31日止年度,公司实现收益1.004亿美元,同比增长20.8%;纯利1843.2万美元,同比增长64.0%;经调整纯利2139.7万美元,同比增长28.7%;基本每股盈利0.0102美元;不派末期股息。
公告表示,2019年度,在北美经营所得收益同比增加33.1%至约7280万美元。撇除货币换算的影响,在中国经营所得收益同比增加1.0%至约人民币1.903亿元。在北美经营所得收益增长主要由于集团进行的营销工作,使得其在北美具有强劲的市场表现;及Concord的设施的毒理学实验室服务逐步增长。中国市场增长放缓,主要是由于2019年下半年部分生物等效性项目延迟,对集团在中国的生物等效性及生物分析相关服务造成负面影响。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.